A carregar...
ERCC1 and BRCA1 mRNA expression levels in metastatic malignant effusions is associated with chemosensitivity to cisplatin and/or docetaxel
BACKGROUND: One of the major challenges in currently chemotherapeutic theme is lacking effective biomarkers for drug response and sensitivity. Our current study focus on two promising biomarkers, ERCC1 (excision repair cross-complementing group 1) and BRCA1 (breast cancer susceptibility gene 1). To...
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2008
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2394535/ https://ncbi.nlm.nih.gov/pubmed/18402708 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-8-97 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|